DMRA

Damora Therapeutics, Inc. Common Stock

12 hedge funds and large institutions have $633K invested in Damora Therapeutics, Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$91.3K
2 +$68.7K
3 +$44.5K
4
Bank of America
Bank of America
North Carolina
+$17.9K
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.69K

Top Sellers

1 -$45.2K
2 -$45.2K
3 -$7.63K
4
Barclays
Barclays
United Kingdom
-$152